Vimarsana
Biggest News Aggregation in the World

Page 3 - Accessed August News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed August Today - Breaking & Trending Today

European Commission Approves Pfizer's ELREXFIO® for Relapsed and Refractory Multiple Myeloma -December 08, 2023 at 07:56 am EST - Vimarsana News

European Commission Approves Pfizer's ELREXFIO® for Relapsed and Refractory Multiple Myeloma -December 08, 2023 at 07:56 am EST

Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial ELREXFIO is an off-the-shelf ,...

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions - Vimarsana News

Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions

With 5.6 months of additional follow-up and 78.3% of patients having completed Kisqali® (ribociclib) investigational treatment, the updated analysis shows...

European Commission Approves Pfizer's ELREXFIO for Relapsed and Refractory Multiple Myeloma - Vimarsana News

European Commission Approves Pfizer's ELREXFIO for Relapsed and Refractory Multiple Myeloma

08.12.2023 - Pfizer Inc. (NYSE:PFE) today announced the European Commission (EC) has granted conditional marketing authorization for ELREXFIO (elranatamab). ELREFXIO is a targeted immunotherapy for the treatment of adult patients with relapsed and refractory ...

One man's story gives hope to those with treatment-resistant depression - Vimarsana News

One man's story gives hope to those with treatment-resistant depression

(BPT) - When the COVID-19 pandemic hit in 2020, Ben, who had already been diagnosed with clinical depression in 2018, felt his depressive symptoms increase the more isolated he became.

One man's story gives hope to those with treatment-resistant depression - Vimarsana News

One man's story gives hope to those with treatment-resistant depression

(BPT) - When the COVID-19 pandemic hit in 2020, Ben, who had already been diagnosed with clinical depression in 2018, felt his depressive symptoms increase the more isolated he became.